GlaxoSmithKline | Pre Utilidad Fiscal



Pre Tax Profit Cambio Fecha
AbbVie USD 1.66B 3.15B 2025-03
Alcon AG USD 199M 215M 2025-06
Almirall EUR 35.8M 37.9M 2025-03
Amgen USD 1.57B 405M 2025-06
argenx SE USD 286.9M 84.54M 2025-06
AstraZeneca USD 3.13B 275M 2025-06
Bayer EUR -426000000 2.26B 2025-06
Biogen USD 744M 432.8M 2025-06
Bristol-Myers Squibb USD 1.77B 1.2B 2025-06
Eli Lilly USD 6.78B 3.32B 2025-06
Fresenius EUR 491M 120M 2025-06
Fresenius Medical Care EUR 350.55M 99.9M 2025-06
Galapagos EUR -156367000 175.4M 2025-03
Genmab DKK 423M 179M 2025-06
Gilead Sciences USD 2.43B 780M 2025-06
GlaxoSmithKline GBP 1.89B 221M 2025-06
Glaxosmithkline USD 1.66B 1.78B 2024-12
GRIFOLS EUR 190.51M 20.03M 2025-06
Hikma Pharmaceutical USD 144M 144M 2024-06
Lonza CHF 624M 197M 2024-12
Merck EUR 829M 127M 2025-06
Merck USD 6.77B 864M 2025-06
Novartis USD 4.53B 124M 2025-06
Novo Nordisk 33.8B 3.23B 2025-06
Orion EUR 103.4M 26.6M 2025-06
Pfizer USD 3.04B 259M 2025-06
Philips EUR 337M 28M 2025-06
Recordati EUR 119.49M 45.37M 2025-06
Regeneron Pharmaceuticals USD 1.52B 613.7M 2025-06
Roche Holding CHF 1.78B 2.33B 2024-12
Sanofi EUR 1.42B 734M 2025-06
Smith & Nephew 469M 70M 2025-06
UCB EUR 1.22B 781M 2024-12


GlaxoSmithKline Pre Utilidad Fiscal - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Aug 2025.